Lembas
PrivateLast Round
Pre Seed
Jun 11, 2025
Total Funding Raised
$3.6M
Company Overview
Lembas is a biotechnology company that has developed an AI-powered discovery platform to create bioactive ingredients for functional foods and supplements, with a first product aimed at appetite regulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B2C
Customer Profile
Data as a Service, Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lembas Comps
Public and private peers based on sector, stage, and business model.
Lembas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 11, 2025 |
Key People
Founding team and executive leadership
Lembas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fresh.Fund | Pre Seed |
| FLORA Ventures | Pre Seed |
| SDH Ventures | Pre Seed |
| Maia Ventures | Pre Seed |
| Longevity Venture Partners | Pre Seed |
| Bluestein Ventures | Pre Seed |
| Mandi Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 11, 2025
$4M raised in Pre Seed round.
Lembas Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lembas's valuation, stock price, and market status.
